Therapeutic Group: Anti Diabetic Presentation Eltero 5: Each film-coated tablet contains Ertugliflozin L Pyroglutamic Acid INN, equivalent to Ertugliflozin 5 mg. Eltero 15: Each film-coated tablet contains Ertugliflozin L Pyroglutamic Acid INN, equivalent to Ertugliflozin 15 mg. Description SGLT2 is the predominant transporter responsible for the reabsorption of glucose from the glomerular filtrate back into […]
Therapeutic Group: Antibiotic Presentation Wandara TM : Each vial contains sterile lyophilized powder of Ertapenem for Injection INN equivalent to Ertapenem 1 gm. Description Ertapenem for Injection is a sterile, synthetic, long-acting, parenteral, 1-β methyl-carbapenem that is structurally related to beta-lactam antibiotics, such as penicillins and cephalosporins, with activity against a wide range of Gram-positive […]
Therapeutic Group: Oncology Presentation Erlocent 100: Each tablet contains Erlotinib Hydrochloride INN equivalent to Erlotinib 100 mg. Erlocent 150: Each tablet contains Erlotinib Hydrochloride INN equivalent to Erlotinib 150 mg. Description Erlotinib, a kinase inhibitor, is a quinazolinamine with the chemical name N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)4-quinazolinamine. Erlotinib reversibly inhibits the kinase activity of EGFR, preventing autophosphorylation of tyrosine […]
Therapeutic Group: Mucolytic drug Presentation Spusoft Capsule: Each capsule contains Erdosteine INN 300 mg Description Erdosteine is a mucolytic drug. It is a prodrug and it becomes active after metabolism. It acts by reducing the viscosity of mucus. In addition, it has asignificant antioxidant action and it inhibits bacterial adhesion to epithelial cells. Indications Erdosteine […]
Therapeutic Group: Cardiovascular Presentation Integril 2 Injection: Each ml of sterile solution contains Eptifibatide INN 2 mg. Integril 0.75 Injection: Each ml of sterile solution contains Eptifibatide INN 0.75 mg. Description Eptifibatide is a cyclic heptapeptide containing six amino acids and one mercaptopropionyl (des-amino cysteinyl) residue. Integril binds to the platelet receptor glycoprotein (GP) IIb/IIIa […]
Therapeutic Group: Cardiovascular Presentation Epleron 25: Each tablet contains Eplerenone INN 25 mg. Description Eplerenone is a blocker of aldosterone binding at the mineralocorticoid receptor. Eplerenone binds to the mineralocorticoid receptor and blocks the binding of aldosterone, a component of the renin-angiotensin-aldosterone-system (RAAS). Aldosterone synthesis, which occurs primarily in the adrenal gland, is modulated by […]
Therapeutic Group: Anti Viral, Hepatitis B Medication Presentation Barcavir 0.5 : Each box contains 1 blister strip of 20 tablets. Barcavir 1: Each box contains 1 blister strip of 20 tablets Description Entecavir is a guanosine nucleoside analogue with activity against HBV polymerase. Entecavir functionally inhibits all activities of the HBV polymerase (reverse transcriptase). Indications […]
Therapeutic Group: Cardiovascular Presentation Active ingredient: Enoxaparin Sodium BP. Solvent: Water for injections BP. Each ml of the solution contains: 10000 anti-Xa IU equivalent to 100 mg Enoxaparin Sodium. Parinox 20: Each pre-filled syringe (0.2ml) contains 2000 anti-Xa IU equivalent to Enoxaparin Sodium BP 20 mg. Parinox 40: Each pre-filled syringe (0.4ml) contains 4000 anti-Xa […]
Therapeutic Group: Sodium-glucose Co-transporter 2 inhibitor Presentation EmpatabTM M 5/500: Each tablet contains Empagliflozin INN 5 mg and Metformin Hydrochloride BP 500 mg. Description Empagliflozin (Sodium-glucose co-transporter-2 inhibitor) and Metformin (biguanide) is a combination of two oral antihyperglycemic drugs with complimentary mechanism of action to improve glycemic control in patients with type-2 diabetes mellitus. Empagliflozin […]
Therapeutic Group: Sodium-glucose Co-transporter 2 inhibitor Presentation Empatab 10: Each film coated tablet contains Empagliflozin INN 10 mg. Empatab 25: Each film coated tablet contains Empagliflozin INN 25 mg. Description Empagliflozin is an inhibitor of Sodium-glucose co-transporter 2 (SGLT2). By inhibiting SGLT2, Empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for […]